** Ajanta Pharma's AJPH.NS stock rises 3.7% to 2,771 rupees
** Drugmaker signs in-licensing pact with Biocon BION.NS for marketing weight-loss drug semaglutide
** BION will supply semaglutide to AJPH for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, the Middle East and Central Asia - AJPH says
** BION up 0.5% on the day
** Avg rating of 13 analysts on AJPH at "buy"; median PT is 3,115 rupees - data compiled by LSEG
** YTD, AJPH down 5.7% vs pharma index's .NIPHARM 2.1% drop
(Reporting by Kashish Tandon in Bengaluru)
((Kashish.tandon@thomsonreuters.com))